New York, March 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Contract Development Manufacturing Organizations Global Market Report 2023" - https ...

Contract development and manufacturing organizations (CDMOs) provide outsourcing options to biotechnology and pharmaceutical companies, helping them advance their drugs from the laboratory to the ...

The biopharmaceutical contract manufacturing market is expected to grow at a CAGR of 8.8% during the projected period. The ...

To recognize outstanding efforts by Contract Manufacturing Organization (CMO) companies in pharmaceutical green chemistry in support of pharmaceutical research, development and manufacturing that ...

The Contract Development And Manufacturing Organization Market is projected to reach a multimillion-dollar valuation by 2034, driven by an unexpected compound annual growth rate (7.13) from 2025 to ...

Samsung Biologics, the biotech arm of Samsung, said Monday that its contract manufacturing organization (CMO) deals have ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for hormone-driven ovarian cancer ...

It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic Active Pharmaceutical Ingredients (APIs), Fine Chemical, and Bio. The New Drug ...

Unlike other global contract manufacturing organizations, Samsung Biologics differentiates itself by focusing on biologics modalities. Biologics are large-molecule treatments made from living ...

During a recent quarterly earnings call, the head of one of the busiest contract development and manufacturing organizations (CDMOs) warned that in the coming months, biopharma companies will ...